![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
PE Stewart and DL Hammond
Department of Anesthesia and Critical Care, University of Chicago, Illinois.
The role of spinal delta opioid receptors in mediating antinociception was studied by using the carrageenan-induced model of thermal hyperalgesia. Intrathecal administration of [D-Ala2, Glu4]-deltorphin (DELT), a delta-2 receptor agonist, or DPDPE, a delta-1 receptor agonist, produced a dose-dependent increase in paw-flick latency (PFL) with an ED50 of 14.0 micrograms for DELT and 30.4 micrograms for DPDPE. DAMGO, a mu receptor agonist, also increased the PFL in a dose- dependent manner when administered intrathecally with an ED50 of 0.02 microgram. Each opioid agonist increased the PFL to values that exceeded base-line latencies determined before the injection of carrageenan. However, DELT and DPDPE increased the PFL to a greater extent than did DAMGO. Coadministration of 30 micrograms of naltrindole shifted the dose-effect line of DELT to the right by 3.5-fold and that of DPDPE to the right by 2.5-fold, consistent with its characterization as a mixed delta-1/delta-2 receptor antagonist. Coadministration of 3 micrograms of naltriben (NTB) shifted the dose-effect line of DELT to the right by 3.2-fold, whereas 10 micrograms of NTB shifted the dose- effect line of DELT at least 15-fold to the right. Neither dose of NTB antagonized the effects of DPDPE. These data are consistent with characterization of NTB as a selective delta-2 receptor antagonist. The antinociception produced by DAMGO was noncompetitively antagonized by 30 micrograms of naltrindole and it was competitively antagonized by 10 micrograms of NTB. Thus, although NTB distinguishes between delta-1 and delta-2 opioid receptors, high doses may not effectively distinguish between delta and mu receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  A. H. Ahn and A. I. Basbaum Tissue Injury Regulates Serotonin 1D Receptor Expression: Implications for the Control of Migraine and Inflammatory Pain. J. Neurosci., August 9, 2006; 26(32): 8332 - 8338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gendron, A. L. Lucido, F. Mennicken, D. O'Donnell, J.-P. Vincent, T. Stroh, and A. Beaudet Morphine and Pain-Related Stimuli Enhance Cell Surface Availability of Somatic {delta}-Opioid Receptors in Rat Dorsal Root Ganglia J. Neurosci., January 18, 2006; 26(3): 953 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Sluka, J. J. Rohlwing, R. A. Bussey, S. A. Eikenberry, and J. M. Wilken Chronic Muscle Pain Induced by Repeated Acid Injection Is Reversed by Spinally Administered {micro}- and delta -, but Not kappa -, Opioid Receptor Agonists J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1146 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Brandt, M. S. Furness, K. C. Rice, B. D. Fischer, and S. S. Negus Studies of Tolerance and Dependence with the delta -Opioid Agonist SNC80 in Rhesus Monkeys Responding under a Schedule of Food Presentation J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 629 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Brandt, M. S. Furness, N. K. Mello, K. C. Rice, and S. S. Negus Antinociceptive Effects of {delta}-Opioid Agonists in Rhesus Monkeys: Effects on Chemically Induced Thermal Hypersensitivity J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 939 - 946. [Abstract] [Full Text]
|
|
|
|
|
|
C. G. Acosta and H. S. Lopez delta Opioid Receptor Modulation of Several Voltage-Dependent Ca2+ Currents in Rat Sensory Neurons J. Neurosci., October 1, 1999; 19(19): 8337 - 8348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Negus, M. B. Gatch, N. K. Mello, X. Zhang, and K. Rice Behavioral Effects of the Delta-Selective Opioid Agonist SNC80 and Related Compounds in Rhesus Monkeys J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 362 - 375. [Abstract] [Full Text]
|
|
|
|
|
|
D. L. Hammond, H. Wang, N. Nakashima, and A. I. Basbaum Differential Effects of Intrathecally Administered Delta and Mu Opioid Receptor Agonists on Formalin-Evoked Nociception and on the Expression of Fos-like Immunoreactivity in the Spinal Cord of the Rat J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 378 - 387. [Abstract] [Full Text]
|
|
|
|
|
|
S. N. Thorat and D. L. Hammond Modulation of Nociception by Microinjection of Delta-1 and Delta-2 Opioid Receptor Ligands in the Ventromedial Medulla of the Rat J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1185 - 1192. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
